Dafna Capital Management LLC Incyte Corp Transaction History

Dafna Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $1.37 Million - $1.9 Million	-21,500 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$60.85 - $83.98 $395,525 - $545,870	6,500 Added 43.33%	21,500 $1.44 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $1.25 Million - $1.51 Million	15,000 New	15,000 $1.25 Million

697

188M

585K

410K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.